Ober Scharrer to acquire SpaMedica from CBPE Capital for $387m.

Ober Scharrer, a provider of outpatient treatment, agreed to acquire SpaMedica, a provider of eye healthcare services, from CBPE Capital, a private equity firm, for $387m. CBPE Capital accelerated the sale process, choosing a buyer more quickly than expected due to concerns that fallout from the coronavirus outbreak could hamper a deal.